Quinn Opportunity Partners LLC - PEREGRINE PHARMACEUTICALS IN ownership

PEREGRINE PHARMACEUTICALS IN's ticker is PPHM and the CUSIP is 713661502. A total of 52 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is 0.30 and the average weighting 0.5%.

Quarter-by-quarter ownership
Quinn Opportunity Partners LLC ownership history of PEREGRINE PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2017$357,000
+83.1%
92,000
+48.1%
0.06%
+87.1%
Q3 2017$195,00062,1000.03%
Other shareholders
PEREGRINE PHARMACEUTICALS IN shareholders Q3 2017
NameSharesValueWeighting ↓
Tappan Street Partners LLC 2,871,000$9,015,00025.26%
Bandera Partners LLC 555,000$1,743,0001.52%
Fondren Management LP 205,000$644,0000.52%
ALGERT GLOBAL LLC 120,521$378,0000.09%
Brown Advisory Securities, LLC 82,858$260,0000.06%
Quinn Opportunity Partners LLC 62,100$195,0000.03%
PDT Partners, LLC 82,800$260,0000.01%
A.R.T. Advisors, LLC 44,766$140,0000.01%
Alambic Investment Management, L.P. 14,500$46,0000.01%
KENNEDY CAPITAL MANAGEMENT LLC 69,820$219,0000.00%
View complete list of PEREGRINE PHARMACEUTICALS IN shareholders